Nanoformulation of CCL21 Greatly Increases Its Effectiveness as an Immunotherapy for Neuroblastoma

Neuroblastoma is the most commonly diagnosed extracranial solid tumor in children. The patients with aggressive metastatic disease or refractory/relapsed neuroblastoma currently face a dismally low chance of survival. Thus, there is a great need for more effective therapies for this illness. In prev...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Control Release
Main Authors: Poelaert, Brittany J., Romanova, Svetlana, Knoche, Shelby M., Olson, Madeline T., Sliker, Bailee H., Smits, Kaitlin, Dickey, Brittney L., Moffitt-Holida, Alexandra E. J., Goetz, Benjamin T., Khan, Nuzhat, Smith, Lynette, Band, Hamid, Mohs, Aaron M., Coulter, Donald W., Bronich, Tatiana K., Solheim, Joyce C.
Formato: Artigo
Idioma:Inglês
Publicado em: 2020
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7606783/
https://ncbi.nlm.nih.gov/pubmed/32711026
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jconrel.2020.07.024
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados